211 public posts
Want to take advantage of all our features? Just log in!
or
Bloomberg News wants to talk with you
We've gathered some examples of such medicines -- including the new KRAS drugs, some older targeted therapies, and the multiple myeloma treatment Ninlaro. Other treatments we are particularly interested in include cabozantinib, afinitor, and Trodelvy.
Does cognitive decline accelerate in older adults after diagnosis with CLL compared with the cognitive trajectory seen in normal aging?
[/i]
[i]
[/i]
[i]https://jamanetwork.com/journals/jamanetworkopen/article-abstract/2823017[/i]
[i]
[/i]
[i]Within the HMN cohort, the most common diagnoses were myeloproliferative neoplasm (127 patients [19.0%]), chronic leukemia (106 patients [15.9%]), and multiple myeloma (97 patients [14.5%]).